Annual Working Capital
$40.80 M
-$492.00 K-1.19%
December 31, 2023
Summary
- As of March 7, 2025, KYTX annual working capital is $40.80 million, with the most recent change of -$492.00 thousand (-1.19%) on December 31, 2023.
- During the last 3 years, KYTX annual working capital has fallen by -$20.35 million (-33.28%).
- KYTX annual working capital is now -33.28% below its all-time high of $61.16 million, reached on December 1, 2021.
Performance
KYTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$294.39 M
-$30.96 M-9.51%
September 30, 2024
Summary
- As of March 7, 2025, KYTX quarterly working capital is $294.39 million, with the most recent change of -$30.96 million (-9.51%) on September 30, 2024.
- Over the past year, KYTX quarterly working capital has increased by +$253.58 million (+621.45%).
- KYTX quarterly working capital is now -16.75% below its all-time high of $353.62 million, reached on March 31, 2024.
Performance
KYTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
KYTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.2% | +621.5% |
| 3 y3 years | -33.3% | +621.5% |
| 5 y5 years | -33.3% | +621.5% |
KYTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.3% | at low | -16.8% | +621.5% |
| 5 y | 5-year | -33.3% | at low | -16.8% | +621.5% |
| alltime | all time | -33.3% | at low | -16.8% | +621.5% |
Kyverna Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $294.39 M(-9.5%) |
| Jun 2024 | - | $325.35 M(-8.0%) |
| Mar 2024 | - | $353.62 M(+766.6%) |
| Dec 2023 | $40.80 M | $40.80 M(-34.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $62.54 M(+51.4%) |
| Dec 2022 | $41.30 M(-32.5%) | - |
| Dec 2022 | - | $41.30 M |
| Dec 2021 | $61.16 M | - |
FAQ
- What is Kyverna Therapeutics annual working capital?
- What is the all time high annual working capital for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual working capital year-on-year change?
- What is Kyverna Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly working capital year-on-year change?
What is Kyverna Therapeutics annual working capital?
The current annual working capital of KYTX is $40.80 M
What is the all time high annual working capital for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual working capital is $61.16 M
What is Kyverna Therapeutics annual working capital year-on-year change?
Over the past year, KYTX annual working capital has changed by -$492.00 K (-1.19%)
What is Kyverna Therapeutics quarterly working capital?
The current quarterly working capital of KYTX is $294.39 M
What is the all time high quarterly working capital for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly working capital is $353.62 M
What is Kyverna Therapeutics quarterly working capital year-on-year change?
Over the past year, KYTX quarterly working capital has changed by +$253.58 M (+621.45%)